Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David S. who wrote (2746)	11/12/1997 9:59:00 PM
From: Joe E.	of 6136

<<If you want to look at valuations, I just glanced at Vertex estimates. For 1999, consensus is $1.93,which puts it at 19x. Consensus for AGPH for '99 = about $2.00, since FY '99=$1.76 consensus. So, AGPH is at 20x cal. '99>> IMO Vertex may not have any product sales in 1999. Probably will, but not necessarily. Agouron will have product sales, and they are not so hard to forecast, given that the company has a track record now. So this makes Vertex's earnings forecast a little less solid than Agouron's. Vertex is rolling in cash, though. Merck is at about 17x '99 EPS.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next